[weglot_switcher]

United States of
America

USA FDA Cosmetic Compliance & MoCRA Regulatory Support

The United States remains one of the largest cosmetic markets in the world—yet its regulatory landscape has undergone its biggest shift in decades following the introduction of MoCRA (Modernization of Cosmetics Regulation Act). gcrs group helps global brands navigate FDA requirements, MoCRA obligations, labelling rules, safety substantiation, and U.S. market entry with streamlined, end-to-end support.

Whether you’re launching your first product in the US or expanding an established portfolio, our experts guide you through every regulatory requirement with clarity and confidence. 

Your Global-to-USA Market Entry Partner

Entering the US market demands more than basic documentation—it requires a clear understanding of how the FDA regulates cosmetics, the new MoCRA requirements, and how your existing global dossier (EU PIF, UK RP documentation, GCC files, BIS India compliance) translates into the U.S. system. 

gcrs group specialises in supporting global brands with: 

  • U.S. cosmetic compliance strategy
  • MoCRA readiness assessments
  • FDA-aligned labelling & warnings
  • Global dossier harmonisation
  • Facility registration & product listing
  • Support for U.S. distributors & importers

With teams across the UK, EU, India, GCC, and the USA, we act as your dedicated regulatory partner—ensuring every product entering the U.S. market is safe, substantiated, and compliant. 

MoCRA Compliance Requirements

(What Brands Must Now Do) 

MoCRA introduced mandatory requirements that all cosmetic brands must follow to sell in the U.S. 

MoCRA Compliance Checklist:

  • Facility Registration (renewed every 2 years)
  • Product Listing for each SKU
  • Safety Substantiation (similar to EU safety evidence)
  • Mandatory GMP Requirements
  • Serious Adverse Event Reporting
  • Fragrance Allergen Disclosure (upcoming rule)
  • Record-Keeping & Documentation for inspections 

MoCRA Timeline

How gcrs group Supports Global Compliance

Market Entry Support for USA

Launching into the U.S. requires aligning global documentation with MoCRA and FDA standards. gcrs group provides a streamlined pathway to ensure your product is ready for import, listing, and sale. 

Key elements include: 

  • Regulatory pathway analysis
  • Safety documentation review
  • Label and packaging compliance  Product listing + facility registration
  • Ingredient and claims assessment
  • GMP implementation guidance
  • Distributor/importer compliance oversight 

Our team ensures your entry into the U.S. market is safe, lawful, and commercially successful.

How the FDA Regulates Cosmetics

Cosmetics in the US are regulated under the Federal Food, Drug, and Cosmetic Act (FD&C Act). Unlike the EU, the FDA does not require pre-market approval for most cosmetics (except colour additives), but brands must ensure: 

  • Correct labelling & ingredient declarations
  • No misleading or unapproved claims
  • No adulterated or contaminated ingredients
  • Compliance with Good Manufacturing Practices (GMP)
  • Proper record-keeping and traceability
  • Safety substantiation for every product 

The FDA frequently issues warning letters, import alerts, and enforcement actions for misbranded or unsafe cosmetics—making proactive compliance essential. 

FDA Cosmetic Labelling Requirements

Accurate labelling is one of the most common reasons products are rejected at the border or flagged by the FDA. 

Key elements include: 

  • INCI-based ingredient lists
  • Net quantity declaration
  • Warning statements (when required)
  • Correct placement of manufacturer/distributor address
  • Country of origin rules
  • Colour additives approved for intended use
  • No medical or drug-like claims 

gcrs group reviews labels in line with both FDA rules and COSMOS/EU/UK standards to ensure global consistency. 

Support for International Brands Entering the U.S. 

Most U.S. regulatory challenges arise because global documentation (EU PIF, UK RP files, GCC dossiers) doesn’t map directly to MoCRA. 

gcrs group bridges that gap by:

  • Harmonising global technical documentation for U.S. standards 
  • Identifying gaps in safety substantiation
  • Adapting claims, warnings, and marketing messages
  • Ensuring labels meet American formatting rules
  • Preparing documentation for FDA inspections 
  • Aligning manufacturing practices with MoCRA-required GMP 

This ensures a seamless global-to-USA transition. 

USA vs UK vs EU Cosmetic Regulation

Topic
Regulatory Authority
Primary Regulation
Responsible Entity
Pre-Market Requirement
Safety Documentation
Language Requirements
Post-Market Obligations
USA
U.S. Food and Drug Administration (FDA)
FDA & MoCRA
Responsible Person (as defined under MoCRA)
Facility Registration & Product Listing
Safety Substantiation
English
Mandatory Adverse Event Reporting
UK
Office for Product Safety & Standards (OPSS)
UK Cosmetics Regulation
UK Responsible Person (RP)
SCPN notification before placing on the market
CPSR & PIF
UK RP Details & English
Mandatory Cosmetovigilance
EU
European Commission (EC) & Member State Competent Authorities
EU Cosmetics Regulation (EC) No. 1223/2009t
EU Responsible Person (RP)
CPNP notification before placing on the market
CPSR & PIF
EU RP Details & Local EU Language(s)
Mandatory Cosmetovigilance

While the UK and EU rely on Responsible Person models and pre-market notification, the USA operates under the FDA's MoCRA framework, which requires facility registration, product listing, and safety substantiation rather than CPSRs and Responsible Person obligations used in Europe. The USA also has distinct post-market adverse event reporting requirements. Understanding these regulatory differences is essential for successful market entry. gcrs group supports cosmetics, fragrance, personal care, food and dietary supplement brands with regulatory compliance and market access across more than 125 countries.

What gcrs group Does for You

gcrs group provides end-to-end USA-focused compliance solutions:

  • Full FDA & MoCRA compliance management
  • Global documentation alignment (EU, UK, GCC, India → USA)
  • Formula & ingredient review
  • Label and artwork correction
  • GMP & documentation readiness  Facility registration + product listing
  • Adverse event reporting support
  • Market entry strategy & importer guidance
  • CRFT platform integration for document management 

We ensure your products enter the U.S. market safely, efficiently, and with full regulatory confidence.

Frequently Asked Questions

Do cosmetics need FDA approval?

No. The FDA does not pre-approve most cosmetics. However, colour additives do require FDA approval, and all products must be safe and properly labelled. 

What are the key MoCRA requirements for cosmetic brands? 

MoCRA introduced facility registration, product listing, safety substantiation, adverse event reporting, GMP, and new labelling rules. 

What does the FDA require for cosmetic labelling? 

INCI ingredients, net quantity, warnings, correct address format, colour additive approval, and no medical claims. 

How do international brands prepare for the U.S. market?

By harmonising global documentation for MoCRA, adjusting claims, updating labels, and completing facility registration + product listing. 

Do foreign manufacturers need a U.S. representative?

Yes. Foreign brands must designate a U.S. point of contact for MoCRA compliance and adverse event handling. 

Get your cosmetic products fully compliant for the U.S. market